Navigation Links
Flaxseed Fails as Treatment for Hot Flashes
Date:6/5/2011

By Amanda Gardner
HealthDay Reporter

SUNDAY, June 5 (HealthDay News) -- The search for a safe remedy for menopausal hot flashes has been foiled again, with flaxseed the latest in a long line of compounds that apparently don't reduce the incidence of the unpleasant symptoms.

Researchers presenting a new study Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago report that a daily flaxseed bar was no more effective than a placebo in helping with hot flashes in women with or without breast cancer.

"It's unfortunate because these are such common problems, not just in breast cancer survivors but in postmenopausal women in general," said Dr. Joanne E. Mortimer, director of women's cancers programs at City of Hope Cancer Center in Duarte, Calif. "These poor women have one less option." Mortimer was not involved with the study.

Hot flashes often occur in breast cancer patients who have undergone hormonal treatment for their tumors as well as in women going through normal menopause.

"Women who are taking endocrine [hormone] therapy and have significant side effects may be less likely to be adherent to treatment, and that leads to worse outcomes," said Dr. Erica L. Mayer, a breast oncologist with Dana Farber Cancer Institute in Boston, who also was not involved with the new research.

Estrogen therapy has been shown to be effective in reducing the incidence of hot flashes but not without a hefty health cost, including a heightened risk of stroke and blood clots.

Flaxseed contains lignans, which can work against estrogen.

"Anecdotally it [flaxseed] has been thought to improve hot flashes and they [the researchers behind the new study] had some pilot data from a non-randomized trial that women who took flaxseed had decreased hot flashes," said Mayer. "That led to the current trial."

For the new study, almost 200 postmenopausal women who reported having at least 28 hot flashes a week were randomly selected to receive either a placebo or a daily flaxseed bar for six weeks.

About half of the women had had breast cancer and half had not.

Although both groups of women reported declines in the number of hot flashes they were experiencing, that number was about the same in each group, with about a third in each group reporting a 50 percent reduction in symptoms.

There were also side effects in both groups, namely bloating, diarrhea and nausea, most likely due to the fiber in the placebo and flaxseed bars, said study author Sandhya Pruthi, an associate professor of medicine at the Mayo Clinic in Rochester, Minn.

"This is a much more complex brain process that we need to understand," said Mortimer. "Negative studies like this [should] spur us on to find the biological mechanisms behind this [hot flashes]. Right now, we don't even know the mechanisms."

Various antidepressants such as Effexor and Zoloft have been shown to be effective against hot flashes, as has acupuncture, said Mayer.

Still, she added, "This is a disappointing study in that it didn't confirm what we had previously seen, but it supports further high-quality, ongoing research to identify agents which are well-tolerated, acceptable to patients and effective in reducing hot flashes so they can stay on therapy and have better breast cancer outcomes."

More information

The U.S. National Library of Medicine has more on menopause.

SOURCES: Erica L. Mayer, M.D., breast oncologist, Dana Farber Cancer Institute, Boston; Joanne E. Mortimer, M.D., director, women's cancers programs, City of Hope Cancer Center, Duarte, Calif.; June 5, 2011, news conference with Sandhya Pruthi, Ph.D., associate professor, medicine, Mayo Clinic, Rochester, Minn.; June 5, 2011, presentation, American Society of Clinical Oncology annual meeting, Chicago


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayo Clinic: Flaxseed no cure for hot flashes during breast cancer or menopause
2. Clues to Why Rheumatoid Arthritis Drug Humira Fails Some Patients
3. Referral to high-volume hospitals for operations fails to improve outcomes statewide
4. Major Drug Review Research Fails to Disclose Funding Sources
5. Home dialysis effective for kidney patients after transplant fails
6. Once-Promising Heart Failure Drug Fails in Trial
7. Device Avoids Open-Heart Surgery When Artificial Valve Fails
8. State Senate Fails Idahoans Struggling With High Health Care Costs
9. Stem cell treatment may offer option for broken bones that dont heal
10. Anorexic girls have increased bone density after physiological estrogen treatment
11. Matching targeted therapies to tumors specific gene mutations key to personalized cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flaxseed Fails as Treatment for Hot Flashes
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength of traditional ... ensures the integrity of biological samples while operating at ultra-high pressures of 20,000 ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over steep cost increases ... D a decade ago, according to The Senior Citizens League (TSCL). ... are coping with rapidly rising costs. “The implications are chilling, particularly for people ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... concussion, yet the cause of injury may be one of many possible sources: ... PT Continuing Education Course , Mastering Rehab Solutions for the Complexities ...
(Date:2/9/2016)... ... February 09, 2016 , ... February is Heart Awareness Month, and ... scans throughout the month to the American Heart Association, New Mexico chapter. , A ... heart disease and Health Quest’s INSiGHT Pulse Wave Profiler utilizes a non-invasive technology to ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... The global prefilled syringes market accounted for $3,905.1 million ... with a CAGR of 12.9% during 2015-2020. Among the ... global prefilled syringes market, with 90.1% share in 2014. ... global market of prefilled syringes is up surging with ... demand for vaccines, increasing prevalence of chronic and lifestyle ...
Breaking Medicine Technology: